Role of Class IIa HDACs HDAC4 and HDAC7 in Pathogenic Th17 Cell Development and Colitis
IIa 类 HDAC HDAC4 和 HDAC7 在致病性 Th17 细胞发育和结肠炎中的作用
基本信息
- 批准号:10711935
- 负责人:
- 金额:$ 40.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:Administrative SupplementAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease testAmyloid beta-ProteinAmyloid beta-Protein PrecursorAttenuatedBrainCD8B1 geneCell Differentiation processCell modelCellsChemicalsClinical TrialsColitisCommunitiesDepositionDevelopmentDoseDrug TargetingExperimental Autoimmune EncephalomyelitisFlow CytometryGeneticGenetic TranscriptionGrantGranulocyte-Macrophage Colony-Stimulating FactorHDAC4 geneHDAC7 histone deacetylaseHealthHippocampusHistone DeacetylaseHistone Deacetylase InhibitorHumanIL17 geneImmunityImpaired cognitionInflammatoryInterferon Type IIInterleukin-10Interleukin-2Knock-in MouseKnockout MiceMediatingMemory impairmentMicrogliaMusNerve DegenerationNeurodegenerative DisordersOutcomeParentsPathogenesisPathogenicityPathologicPathologic ProcessesPathologyPeptidesProcessProductionRegulatory T-LymphocyteResearchRoleSenile PlaquesSpecific qualifier valueTechniquesTherapeuticTreatment EfficacyU-Series Cooperative AgreementsUnited States National Institutes of Healthabeta accumulationapolipoprotein E-4attenuationbehavioral studycell typecognitive functioncytokineempowermentgene repressionglial activationimprovedin vivoinhibitorinterestinterleukin-21interleukin-22interleukin-23mouse modelneuroinflammationnovel therapeutic interventionresponsesexsingle-cell RNA sequencingtrend
项目摘要
PROJECT SUMMARY
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder of aging. The major pathological
hallmark of AD in the brain amyloid plaques consists of amyloid β peptide-40 (Aβ40) and peptide-42 (Aβ42) that
are produced from amyloid precursor proteins by sequential cleavage. However, nearly all experimental drugs
targeting Aβ cleavage and processing tested for AD have failed to show significant efficacy. Alternative
therapeutic options are being explored, as accumulating evidence has indicated that Aβ accumulation alone
cannot explain much of the pathogenesis of AD, indicating the involvement of other pathological processes.
Notably, neuroinflammation has emerged as a key player, as it is initiated by amyloid plaques, followed by
activation of microglia and inflammatory CD4+ T-helper 17 (Th17) cells that eventually leads to
neurodegeneration in the brain. This process is fueled by Th17-secreted inflammatory cytokines IL-17, IL-21,
IL-22, IL-23, IFN-g and GM-CSF that are found to be elevated in AD patients. We recently discovered that
Class IIa HDACs are essential for Th17 cell differentiation, but not Th1, Th2, and Treg subtypes that have
different functions in immunity. Specifically, using genetic knockout mice, we found that Hdac4 activates gene
transcription of Th17 cytokines IL-17A and IL-22 while Hdac7 represses gene transcription of Th17 negative
regulators IL-2 and IL-10. Chemical disruption of HDAC4/7 by TMP269 attenuates inflammatory cytokine
production by pathogenic Th17 cells and blocks Th17 over-development in experimental autoimmune
encephalomyelitis (EAE) mice model and attenuates cognitive impairment in a mouse model of AD.
Collectively, our results suggest that Class IIa HDACs are attractive new targets for neuroinflammation in AD.
项目摘要
阿尔茨海默病(Alzheimer's disease,AD)是最常见的神经退行性疾病。主要病理
脑淀粉样斑块中AD的标志物由淀粉样β肽-40(Aβ40)和肽-42(Aβ42)组成,
由淀粉样前体蛋白通过连续切割产生。然而,几乎所有的实验药物
针对AD测试的靶向Aβ切割和加工未能显示出显著的功效。替代
目前正在探索治疗方案,因为越来越多的证据表明,Aβ积聚本身
不能解释AD的发病机制,表明其他病理过程的参与。
值得注意的是,神经炎症已经成为一个关键因素,因为它是由淀粉样蛋白斑块引发的,然后是
小胶质细胞和炎性CD 4 + T辅助17(Th 17)细胞的活化,最终导致
大脑的神经退化该过程由Th 17分泌的炎性细胞因子IL-17,IL-21,
IL-22、IL-23、IFN-g和GM-CSF在AD患者中升高。我们最近发现
IIa类HDAC对于Th 17细胞分化是必需的,但对于具有Th 1、Th 2和Treg亚型的Th 1、Th 2和Treg亚型不是必需的。
不同的免疫功能。具体来说,使用基因敲除小鼠,我们发现Hdac 4激活基因
Th 17细胞因子IL-17 A和IL-22的转录,而Hdac 7抑制Th 17阴性细胞因子的基因转录。
调节因子IL-2和IL-10。TMP 269对HDAC 4/7的化学破坏减弱了炎性细胞因子
通过致病性Th 17细胞的产生并阻断实验性自身免疫中Th 17的过度发育
在一些实施方案中,本发明提供了一种治疗脑脊髓炎(EAE)小鼠模型的方法,并减轻AD小鼠模型中的认知损害。
总的来说,我们的结果表明,IIa类HDAC是AD神经炎症的有吸引力的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kalung Cheung其他文献
Kalung Cheung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kalung Cheung', 18)}}的其他基金
Mechanism of Transcriptional Regulation of Th2 Cell Development
Th2细胞发育的转录调控机制
- 批准号:
10716014 - 财政年份:2023
- 资助金额:
$ 40.17万 - 项目类别:
Role of Class IIa HDACs HDAC4 and HDAC7 in Pathogenic Th17 Cell Development and Colitis
IIa 类 HDAC HDAC4 和 HDAC7 在致病性 Th17 细胞发育和结肠炎中的作用
- 批准号:
10417716 - 财政年份:2022
- 资助金额:
$ 40.17万 - 项目类别:
Role of Class IIa HDACs HDAC4 and HDAC7 in Pathogenic Th17 Cell Development and Colitis
IIa 类 HDAC HDAC4 和 HDAC7 在致病性 Th17 细胞发育和结肠炎中的作用
- 批准号:
10557888 - 财政年份:2022
- 资助金额:
$ 40.17万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 40.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)